Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis

References

• McConkey B, Amos RS, Durham S, Forster PJG, Hubball S, Walsh L. Sulphasalazine in rheumatoid arthritis. Br Med J 1980; i: 442–4
   Google Scholar
• Pinals RS. Sulphasalapne. in the rheumatic disease. Semin Arthritis Rheumat 1988; 17: 246–59
   PubMed Web of Science ®Google Scholar
• Farr M, Tunn E, Crockson Ap, Bacon PA. The long term effects of suiphdazine in the treatment of rheumatoid arthritis and a comparative study with peniciuarmine. Clin Rheumatol 1984; 3: 473–82
   PubMed Web of Science ®Google Scholar
• Pinals RS, Kaplan SB, Lawson JG, Hepburn B. Sulphasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum 1986; 29: 1427–34
   PubMedGoogle Scholar
• Stenson WF, Lobos E. Sulphasalazine inhibits the synthesis of chemotactic lipids. J Clin Invest 1982; 69: 494–7
   PubMed Web of Science ®Google Scholar
• Barrett KE, Tashof TL, Metcalfe DD. Inhibition of IgE mediated mast cell degranulation by sulphasalazine. Eur J Pharmacol 1985; 102: 279–81
   Google Scholar
• Scott JM, Weir DG. Drug-induced megaloblastic change. Clin Haematol 1980; 9: 587–605
   PubMedGoogle Scholar
• Halsted CH. Intestinal absorption and malabsorption of folates. Ann Rev Mad 1980; 31: 79–87
   PubMed Web of Science ®Google Scholar
• Halsted CH. The intestinal absorption of folates. Am J Clin Nutr 1979; 32: 846–55
   PubMed Web of Science ®Google Scholar
• Reisenauer AM, Halsted CH. Human jejunal brush border folate conjugase. Characteristics and inhibition by salicylazosulphapyridine. Biochim Biophys Acta 1981; 659: 62–9
   PubMedGoogle Scholar
• Halsted CH, Gandhi G, Tamura T. Sulphasalazine inhibits the absorption of folates in ulcerative colitis. N Engl J Med 1981; 305: 1513–17
   PubMed Web of Science ®Google Scholar
• Franklin JL, Rosenberg IH. Impaired folic acid abrption in inflammatory bowel disease: effects of salicylazosulphapyridine (Azulfidine). Gastro-enterology 1973; 64: 517–25
   PubMed Web of Science ®Google Scholar
• No author. clinical nutrition cases. Sulphasalazine inhibits folate absorption. Nutr Rev 1988; 46: 320–3
   PubMedGoogle Scholar
• Swinson CM, Perry J, Lumb M. J', Levi A. Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis. Gut 1981; 22: 456–61
   PubMed Web of Science ®Google Scholar
• Selhub J, Dhar GJ, Rosenberg IH. Inhibition of folate enzymes by sulphasalazine. J Clin Invest 1978; 61: 221–4
   PubMed Web of Science ®Google Scholar
• Wijnands MJ, Nuver-Zwart IH, van Riel PL, van't Hof MA, Gribnau FW, van De Putte LB. Hemolysis during low-dose sulphasalazine treatment in rheumatoid arthritis patients. Scand J Rheumatol 1991; 20: 52–7
   PubMed Web of Science ®Google Scholar
• Goodacre RL, Ali MAM, Vanderlinden B, Hamilton JD, Castelli M, Seaton T. Hemolytic anemia in patients receiving sulphasalazine. Digestion 1978; 17: 503–8
   PubMed Web of Science ®Google Scholar
• Pounder RE, Craven ER, Henthorn JS, Bannatyne JM. Red cell abnormalities associated with sulphadazine maintenance therapy for ulcerative colitis. Gut 1975; 16: 181–5
   PubMed Web of Science ®Google Scholar
• Ralston SH, Willocks LJ, Shaw RW, Pitkeathly DA. Macrocytosis and sulphasalzine treatment of rheumatoid arthritis. Br J Rheumatol 1987; 26: 472–3
   PubMedGoogle Scholar
• Prouse PJ, Shawe D, Gumpel JM. Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis. Br Med J 1986; 293: 1407
   PubMedGoogle Scholar
• Prouse PJ, Shawe D, Gumpel JM. Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis. Br Med J 1987; 294: 904–5
   PubMedGoogle Scholar
• Grindulis KA, McConkey B. Does sulphadazine cause folate deficiency in rheumatoid arthritis?. Scand J Rheumatol 1985; 14: 265–70
   PubMed Web of Science ®Google Scholar
• Schneider RE, Beeley L. Megaloblastic anaemia associated with sulphasalazine treatment. Br Med J 1977; i: 1638–9
   Google Scholar
• Kane SP, Boots MA. Megaloblastic anaemia associated with sulphadazine treatment. Br Med J 1977; ii: 1287–8
   Google Scholar
• Longstreth GF, Green R. Folate status in patients receiving maintenance doses of sulfasalazine. Arch Intern Med 1983; 143: 902–4
   PubMedGoogle Scholar
• Logan ECM, Williamson LM, Ryrie DR. Sulphasalazine associated pancytopenia may be caused by acute folate deficiency. Gut 1986; 27: 858–72
   PubMed Web of Science ®Google Scholar
• Grieco A, Caputo S, Bertoli A, Caradonna P, Greco AV. Megaloblastic anaemia due to sulphasalazine responding to drug withdrawal alone. Postgraduate Med J 1986; 62: 307–8
   PubMed Web of Science ®Google Scholar
• Hopkinson ND, Garcia FS, Gumpel JM. Haematological side-effects of sulphasalazine in inflammatory arthritis. Br J Rheumatol 1986; 28: 414–17
   Google Scholar
• Elsborg L, Larsen L. Folate deficiency in chronic idammatory bowel diseases. Scand J Gastro-enterol 1979; 14: 1019–24
   PubMed Web of Science ®Google Scholar
• Greaves M, Amos RS, Bax D. Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis. Br Med J 1987; 294: 373
   PubMedGoogle Scholar
• Curtis D, Sparrow R, Brennan L, Van Der Weyden MB. Elevated serum homocysteine as a predictor for vitamin B12 or folate deficiency. Eur J Haematol 1994; 52: 227–32
   PubMed Web of Science ®Google Scholar
• Kang S-S, Wong PWK, Norusis M. Homo-cysteinemia due to folate deficiency. Metabolism 1987; 36: 458–62
   PubMed Web of Science ®Google Scholar
• Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989; 114: 473–501
   PubMed Web of Science ®Google Scholar
• Kang S-S, Wong PWK, Curley K. The effect of d-penicillamine on protein-bound homocyst(e)ine in homocystinurics. Pediatr Res 1982; 16: 370–2
   PubMed Web of Science ®Google Scholar
• Morgan SL, Baggott JE, Refsum H, Ueland PM. Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate. Pharmacol Ther 1991; 50: 547–56
   Web of Science ®Google Scholar
• Refsum H, Helland S, Ueland PM. Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment. Pharmacol Ther 1989; 46: 510–20
   Web of Science ®Google Scholar
• Refsum H, Wesenberg F, Ueland PM. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate. Cancer Res 1991; 51: 828–35
   PubMed Web of Science ®Google Scholar
• Joosten E, Pelemans W, Devos P, Lesaffre E, Goossens W, Criel A, et al. Cobalamin absorption and serum homocysteine and methylmalonic acid in elderly patients with low serum cobalamin. Eur J Haematol 1993; 51: 25–30
   PubMed Web of Science ®Google Scholar
• Hultberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol 1993; 40: 230–4
   PubMed Web of Science ®Google Scholar
• Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al. The natural history of homocystinuria due do cystathionine β-synthase deficiency. Am J Hum Genet 1985; 37: 1–31
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Associationrevised criteria for the classilication of rheumatoid arthritis. Arthritis Rheum 1988; 31: 1987, 315–24
   Google Scholar
• Rasmussen K. Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotopedilution method. Clin Chem 1989; 35: 260–4
   PubMed Web of Science ®Google Scholar
• Trivelli LA, Ranney HM, Lai H-T. Hemoglobin components in patients with diabetes mellitus. N Engl J Med 1971; 284: 353–7
   PubMed Web of Science ®Google Scholar
• Schwartz HC, King KC, Schwartz AL, Edmunds D, Schwartz R. Effects of pregnancy on hemoglobin Alc in normal, gestational diabetic, and diabetic women. Diabetes 1976; 25: 1118–22
   PubMed Web of Science ®Google Scholar
• Vester B Rasmussen. High performance liquid chromatography method for rapid and accurate determination of homocystein in plasma and serum. Eur J Clin Chem Biochem 1991; 29: 549–54
   PubMedGoogle Scholar
• Hoffbrand AV, Stewart JS, Booth CC, Molling DL. Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. Br Med J 1968; 2: 71–5
   PubMed Web of Science ®Google Scholar